Bonesupport Holding AB (BONEX)

Currency in SEK
221.60
+2.60(+1.19%)
Closed·
BONEX Scorecard
Full Analysis
Impressive gross profit margins
Trading near 52-week Low
BONEX is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
218.80223.00
52 wk Range
218.80405.80
Key Statistics
Prev. Close
219
Open
219
Day's Range
218.8-223
52 wk Range
218.8-405.8
Volume
149.36K
Average Volume (3m)
181.72K
1-Year Change
-34.13%
Book Value / Share
12.69
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BONEX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
395.20
Upside
+78.34%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Bonesupport Holding AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Bonesupport Holding AB Company Profile

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Employees
143
Market
Sweden

Bonesupport Holding AB Earnings Call Summary for Q2/2025

  • Net sales up 29% YoY (40% in constant currency) to SEK 284M; CERAMENT G U.S. sales surge 84%, totaling SEK 1B since launch
  • Operating result (ex-incentives) SEK 62M; reported EBIT SEK 55M; operating cash flow SEK 50M; gross margin 95% in Europe/RoW
  • Forecasts sales growth above 40% in constant currency for full year; CERAMENT BVF Spine launch planned for December 2025
  • Exploring joint infection prevention market; considering price increases; awaiting FDA approval for CERAMENT V launch in H1 2026
  • Strong financial health: 92.59% gross profit margin, 44.52% revenue growth (LTM), 4.34 current ratio, 0.02 debt-to-equity ratio
Last Updated: 14/10/2025, 16:54
Read Full Transcript

Compare BONEX to Peers and Sector

Metrics to compare
BONEX
Peers
Sector
Relationship
P/E Ratio
96.1x−18.9x−0.6x
PEG Ratio
1.47−0.360.00
Price/Book
17.5x10.0x2.6x
Price / LTM Sales
13.0x49.8x3.4x
Upside (Analyst Target)
69.2%37.5%39.1%
Fair Value Upside
Unlock−6.1%5.4%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 395.20
(+78.34% Upside)

Earnings

Latest Release
Oct 23, 2025
EPS / Forecast
0.52 / 0.89
Revenue / Forecast
294.00M / 309.54M
EPS Revisions
Last 90 days

BONEX Income Statement

People Also Watch

316.0
NOVOb
-2.11%
89.8200
PRY
+2.04%
635.20
EVOG
-2.19%
37.57
KLAR
+2.62%

FAQ

What Stock Exchange Does Bonesupport Trade On?

Bonesupport is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Bonesupport?

The stock symbol for Bonesupport is "BONEX."

What Is the Bonesupport Market Cap?

As of today, Bonesupport market cap is 14.59B.

What Is Bonesupport's Earnings Per Share (TTM)?

The Bonesupport EPS (TTM) is 2.28.

When Is the Next Bonesupport Earnings Date?

Bonesupport will release its next earnings report on 11 Feb 2026.

From a Technical Analysis Perspective, Is BONEX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bonesupport Stock Split?

Bonesupport has split 0 times.

How Many Employees Does Bonesupport Have?

Bonesupport has 143 employees.

What is the current trading status of Bonesupport (BONEX)?

As of 02 Nov 2025, Bonesupport (BONEX) is trading at a price of 221.60, with a previous close of 219.00. The stock has fluctuated within a day range of 218.80 to 223.00, while its 52-week range spans from 218.80 to 405.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.